| Literature DB >> 11435923 |
L Zhang1, D R Rubinow, G Xaing , B S Li, Y H Chang, D Maric, J L Barker, W Ma.
Abstract
The cellular mechanisms underlying the neuroprotective effects of estrogen are only beginning to be elucidated. Here we examined the role of protein kinase B (Akt) activation in 17beta-estradiol (E2) inhibition of beta-amyloid peptide (31-35) (Abeta31-35)-induced neurotoxicity in cultured rat hippocampal neurons. Abeta31-35 (25-30 betaM) significantly decreased the total number of microtubule associated protein-2 positive cells (MAP2+). This decrease was significantly reversed by pre-treatment with 100 nM E2. Further, 100 nM E2 alone significantly increased the total number of protein kinase B and microtubule associated protein-2 positive cells compared with controls. Such E2-induced increases were inhibited by LY294002 (20 microM), a specific PI3-K inhibitor, as well as by tamoxifen, an estrogen receptor antagonist/selective estrogen receptor modulator. These results indicate that the neuroprotective effects of E2 may be mediated at least in part via estrogen receptor-mediated protein kinase B activation.Entities:
Mesh:
Substances:
Year: 2001 PMID: 11435923 DOI: 10.1097/00001756-200107030-00030
Source DB: PubMed Journal: Neuroreport ISSN: 0959-4965 Impact factor: 1.837